PL75, relative had a vaccine and I prepped them about an antibody test to confirm covid protection.
Reply was an antibody test is not needed and cost would be prohibitive!
Seens you may be correct in your assumption!!
Test, test, test
https://science.sciencemag.org/content/early/2021/01/22/science.abf9302
Test, test, test
NeutronDonor, for free float
https://simplywall.st/stocks/gb/diversified-financials/aim-brh/braveheart-investment-group-shares#ownership
36.7% is estimated as free float.
Top 25 shareholders own 61.96% of the company.
Carl's test - fast (tick), sensitive (tick), specific (tick)
Test, test, test
InfinisandBeyond, still long and strong!
The question about whether Avacta actually has submitted production test samples for evaluation is the elephant in the room. Not sure anyone provided a satisfactory answer.
My hope has to be confidentiality prevents Avacta from saying anything!
A further conclusion from what I was saying earlier about Deepblue is that if Avacta's test has the Sensitivity for Pfu/ml greater than 10,000 than Deepblue has, then I would be delighted.
I really wonder what the difference in Specificity, Sensitivity and price is between Deepblue and Avacta??
Admittedly, ideally, there is the question of how both tests perform in Phase 4 trials.
Hopefully, all will be revealed!
Lots of hope from me.
After 100k people deaths announcement we all need some more hope!
Test, test, test
Celtics, great post.
Looking at document, 'COVID-19: Rapid Antigen detection for SARS-CoV-2 by lateral flow
2 assay: a national systematic evaluation for mass-testing', https://www.medrxiv.org/content/10.1101/2021.01.13.21249563v1.full.pdf
Line 163, there is this sentence:
"As part of Phase 2 evaluations, 9,692 LFD tests were performed at PHE Porton Down across the 64 candidate devices as of the 3rd December 2020."
I am not sure that Avacra was in a position to submit a production test by December 3rd, 2020.
Can anyone confirm??
Perhaps a question to consider is:
What business could Avacta get if they submitted a very good test, say, today, for evaluation?
Some thoughts related to Table 1 of the referenced pdf:
* Looking at the Avacta slide, 'Excellent performance of the SARS-CoV-2 ELISA with live coronavirus samples carried out with The Liverpool School of Tropical Medicine'
and cotained in Figure 1a from
https://www.medrxiv.org/content/10.1101/2020.04.16.20067835v1.full.pdf
The lower limit of viral copies AVCT is targeting is perhaps about 7,000 / ml, as estimated by eyeball from a logarithmic scale.
* If reliable detection of viral load above
10, 000 / ml is a reasonable aim, then the Deepblue test looks by far the best in Table 1.
Innova only achieves 88% Sensitivity in the 10,000 to 100,000 Pfu/ml range, as compared to 100% for Deepblue.
Admittedly, Deepblue drops to 98% Sensitivity for 1e5 to 1e6 Pfu/ml, but, even if real, that seems a minor problem.
So, in conclusion, it looks like the UK has bought the wrong Chinese test!
Test, test, test
Goldtrig, agreed...
Just watched KJB, Prof Whitty and Sir Simon Stevens:
One interesting point was BJ saying that the UK has created a Lateral Flow Test industry. Which companies would he be referring to?
Interesting that BJ can look straight at the camera and state that the government has done all it can. BJ said this even after some very pointed questioning that ought to have reminded him of the things he could have done differently.
100k people dead. Very sad day TODAY.....
Test, test, test
Link should have been
https://www.dailymail.co.uk/news/article-9127345/UK-coronavirus-Department-Health-rebranding-professional-use-kit-self-test.html
Test, test, test